Breaking: Transformative Growth in the US Erythropoietin Drug Market
The US erythropoietin drug market is poised for robust expansion, with a projected market size of USD 7 billion by 2035. This growth trajectory, reflecting a compound annual growth rate (CAGR) of 9.65%, demonstrates the increasing demand for erythropoietin therapies, especially among patients suffering from anemia associated with chronic kidney disease (CKD). According to , the market size was...
0 Comments 0 Shares 247 Views 0 Reviews
social art-inpa https://social.art-inpa.com